ReviewBiomolecules2026
ELABELA: A Potential Therapeutic Target for Ischemia-Reperfusion Injury.
Wan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewBiomolecules2026
Wan Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.